A Chinese-made vaccine against the new coronavirus entered the final stage of testing on Tuesday in Brazil, where volunteers received the first doses of what officials hope will be a game-changer in the pandemic.
The vaccine, developed by private Chinese pharmaceutical firm Sinovac, became the third in the world to enter Phase 3 clinical trials, or large-scale testing on humans — the last step before regulatory approval.
“We’re living in unique and historic times, and that’s why I wanted to be part of this trial,” said the 27-year-old doctor who received the first dose at the Clinical Hospital of Sao Paulo.
Sao Paulo Governor Joao Doria said on Monday that initial results were expected within 90 days.
Sinovac is partnering with a Brazilian public health research center, the Butantan Institute, on the trials.
If the vaccine proves safe and effective, the institute will have the right to produce 120 million doses under the deal, according to officials.
Reports from Channels tv
For breaking news and live news updates and more, like us on Facebook or follow us on Twitter and Instagram. Read more on Latest World News and Sports, Entertainment News on Roundnews24.com.
